Golden has been acquired by ComplyAdvantage.Read about it here ⟶

QurAlis

QurAlis is a biotechnology company developing treatments for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

Overview Structured Data Issues Contributors Activity

quralis.com

Is a

Organization

Company

Company attributes

Industry

Biomedical engineering

...

Location

United States

Cambridge, Massachusetts

B2X

B2B

CEO

‌

Kasper Roet

Number of Employees (Ranges)

51 – 2001

Email Address

info@quralis.com3

Phone Number

+17818167031

Full Address

100 Cambridge Park Drive, 5th Floor, Cambridge, MA 02140, US

Investors

Amgen Ventures

Viva Biotech

MP Healthcare Venture Management

BioInnovation Capital

DUNS Number

080705732

Founded Date

2016

Total Funding Amount (USD)

53,000,000

Latest Funding Round Date

May 13, 2020

Latest Funding Type

Series A

Country

United States

Other attributes

Company Operating Status

Active

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

QurAlis Raises $5.5 Million Seed Round

BusinessWire

https://www.businesswire.com/news/home/20181119005047/en/QurAlis-Raises-5.5-Million-Seed

Web

References

Find more companies like QurAlis

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.